Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
grade C 17.51 0.00% 0.00
AMRN closed unchanged on Monday, March 25, 2019, on 56 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
49 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical AMRN trend table...

Date Alert Name Type % Chg
Mar 25 MACD Bearish Centerline Cross Bearish 0.00%
Mar 25 Below Lower BB Weakness 0.00%
Mar 25 Lower Bollinger Band Touch Weakness 0.00%
Mar 25 Oversold Stochastic Weakness 0.00%
Mar 22 Fell Below 50 DMA Bearish 0.00%
Mar 22 New Downtrend Bearish 0.00%
Mar 22 180 Bearish Setup Bearish Swing Setup 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%

Older signals for AMRN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Biopharmaceutical Organic Compounds Nutrition Cardiovascular Diseases Cholesterol Low Density Lipoprotein Lipids Hypertriglyceridemia Saturated Fat
Is AMRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 25 Alibaba and Amarin Among Unanimous Strong Buy Stocks
Mar 25 Implied Volatility Surging for Amarin (AMRN) Stock Options
Mar 22 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KHC, AMRN, WTW and SYNH
Mar 22 Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., and The Kraft Heinz Company
Mar 22 Stifel on Amarin (AMRN): Nothing Fishy About This Stock — It’s a Buy!
Mar 22 CLASS ACTION UPDATE for DPLO, AMRN and BPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Mar 22 Benzinga's Top Upgrades, Downgrades For March 22, 2019
Mar 22 More Biogen downgrades in premarket analyst action
Mar 22 AMARIN ALERT: Gibbs Law Group Has Filed Sole Class Action; Shareholders Should Contact the Firm About Their Rights
Mar 21 SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation plc of Class Action Lawsuit and Upcoming Deadline – AMRN
See more AMRN news...
Indicators
Indicator Value
52 Week High 23.335
52 Week Low 2.35
Average Volume 7,780,594
200-Day Moving Average 12.3273
50-Day Moving Average 18.5074
20-Day Moving Average 20.391
10-Day Moving Average 19.396
Average True Range 1.1855
ADX 35.09
+DI 17.3864
-DI 20.5294
Chandelier Exit (Long, 3 ATRs ) 19.6935
Chandelier Exit (Short, 3 ATRs ) 20.8165
Upper Bollinger Band 23.1933
Lower Bollinger Band 17.5887
Percent B (%b) -0.01
BandWidth 27.485655
MACD Line -0.0877
MACD Signal Line 0.4538
MACD Histogram -0.5415
Fundamentals Value
Market Cap 4.74 Billion
Num Shares 271 Million
EPS -0.31
Price-to-Earnings (P/E) Ratio -56.48
Price-to-Sales 5.87
Price-to-Book 0.00
PEG Ratio -1.74
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.62
Resistance 3 (R3) 18.66 18.33 18.44
Resistance 2 (R2) 18.33 18.05 18.31 18.37
Resistance 1 (R1) 17.92 17.87 18.13 17.88 18.31
Pivot Point 17.59 17.59 17.69 17.57 17.59
Support 1 (S1) 17.18 17.31 17.39 17.14 16.71
Support 2 (S2) 16.85 17.13 16.83 16.65
Support 3 (S3) 16.44 16.85 16.59
Support 4 (S4) 16.40